Botco
San Francisco, US · Founded 2024 · Delaware corporation · 25 employees on LinkedIn · 4 known investors
Botco.ai builds generative AI agents using a Retrieval-Augmented Generation framework to automate tasks such as adverse event reporting, patient referrals, clinical support, and CRM workflows. It serves organizations in healthcare, behavioral health, pharma, provider engagement, and government/citizen services.
Also known as Botco · Botco.ai
Founders & leadership
Botco was founded in 2024 by Kyle Vogt, Rebecca Clyde, and Chris Maeda.
Board
Investors · 4
Reported raises · per SEC filings
Form D private placements$150.7M disclosed across 1 round · 2024
▶$150.7MraisedMay 2024 · 41 investors · Other TechnologyRule 506(b)
- Nabeel HyattDirector
- Daniel GrossDirector
- Kyle VogtExecutive Officer, Director
- Offering amount
- $152.2M
- Amount sold
- $150.7M
- Minimum investment
- $1
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Botco.ai is an enterprise conversational AI vendor that provides a platform of generative AI agents and chatbots for regulated industries, including healthcare, pharma, behavioral health, senior living and public sector organizations. The company describes its offering as a "GenAI Chat Cloud" built on a Retrieval-Augmented Generation (RAG) framework, with fine-tuned models and proprietary data ingestion intended to keep responses grounded and domain-specific. Named products include InstaStack and InstaChat, which the company says allow rapid deployment of chatbots that find, retrieve and present information across stages of the customer journey.
The platform is positioned as no-code, with centralized governance and permissions, configurable handoff from AI agents to live human agents, and an analytics layer providing conversation-level reporting, sentiment analysis and channel performance tracking. Engagement channels include web chat on desktop and mobile, social channels, SMS, voice AI, image and video interactions, and multilingual conversations. Stated use cases span adverse event reporting, patient referrals, patient support and engagement (for example cancer information), appointment scheduling and intake, clinical trial matching and pre-screening, government service automation, CRM workflows, and high-volume inquiry handling.
Compliance is a central positioning element: the company cites HIPAA validation, SOC 2 (Level 2), GDPR and CCPA privacy compliance, field-level encryption and an enterprise security architecture, plus support for additional life sciences and pharma compliance requirements.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 7
by search overlapCompanies competing with Botco for the same Google search keywords, organic and paid, via search-intersection analysis.
Legal entities · 1
corporate structureIn the news
▸Research sources · 8
primary sources listed
- Botcobotco.ai · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Botco do?
- Botco.ai sells a no-code generative AI agent and chatbot platform for regulated sectors such as healthcare, pharma and government.
- Who founded Botco?
- Botco was founded by Kyle Vogt, Rebecca Clyde, Chris Maeda in 2024.
- Who are Botco's investors?
- Botco's investors include PHX Ventures, Sterling Road, VamosVentures, Spark Capital.
- How much funding has Botco raised?
- Botco has disclosed $150.7M raised across 1 round.
- Where is Botco headquartered?
- Botco is headquartered in San Francisco, US.






